MedPath

Effectiveness of an Online Bulletin Board for Depression: a Longitudinal Randomized Controlled Trial

Early Phase 1
Withdrawn
Conditions
Depression
Interventions
Other: bulletin board
Registration Number
NCT01423448
Lead Sponsor
Louise Farrer
Brief Summary

This study is a randomised controlled trial that aims to examine the efficacy of an established online bulletin board for depression. It has been estimated that millions of people worldwide use peer-to-peer bulletin boards, forums or internet support groups (ISGs) for health conditions. However, little is known about the effectiveness of these groups in terms of symptom reduction or improvement in quality of life. The current project investigates the effectiveness of an established online bulletin board for depression available to the public. To our knowledge, this is the first randomised controlled trial of the effectiveness of a pre-existing, well-established online bulletin board for depression in the community. The aims of the project are to determine whether the bulletin board improves mental health, quality of life, and related outcomes among members of the community with high levels of self-reported psychological distress and previous history or current experience of depression.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Over 18 years of age
  2. Internet access with email
  3. Self-report of current or previous experience of depression
Exclusion Criteria
  1. Current participation in an online support group for depression
  2. Diagnosis of bipolar disorder, schizophrenia, or psychosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Bulletin boardbulletin boardParticipants will be given access to the online bulletin board (intervention) for a 6 month period
Primary Outcome Measures
NameTimeMethod
Depressive symptoms: Centre for Epidemiological Studies - Depression Scale (CES-D)12 months post-baseline

20-item self -report measure of depression severity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre for Mental Health Research, The Australian National University

🇦🇺

Canberra, Australian Capital Territory, Australia

© Copyright 2025. All Rights Reserved by MedPath